Chronic apathy following a major depressive episode: What is it?

Distinguishing between neurological and psychiatric disorders can be challenging, particularly when apathy serves as the primary symptom, as it is a common manifestation in both neurodegenerative diseases and mood disorders. We present a cohort of 11 patients (7 females and 4 males) aged over 50 years (mean age 61.36 ± 5.870 SD). These individuals exhibited a prolonged and isolated apathy lasting over a year, without concurrent dysthymia, but with a history of a preceding major depressive episode. This article aims to comprehensively profile these patients and to explore whether this condition represents an unconventional clinical presentation of a well-established disorder or introduces a hitherto unrecognized clinical entity. Key characteristics of this group included the following: sustained use of one or more typically effective antidepressant medications during the depressive episode prior to the onset of apathy, with no improvement of apathy during follow-up; a partial response to a single dose of zolpidem; the presence of a dysexecutive syndrome, with minimal or absent neurological signs except for mild extrapyramidal signs in a subset of patients; and the identification of mesial frontal abnormalities in neuroimaging studies (involving atrophy and/or hypoperfusion and/or hypometabolism) in eight patients. Only two patients received a neurological diagnosis during follow-up, characterized by a DAT Scan suggestive of Parkinson's disease. The underlying cause of this syndrome remains uncertain, possibly multifactorial, and yet to be determined. To advance understanding and treatment of this condition, it is imperative for neurologists and psychiatrists to be aware of and recognize this syndrome.

Authors

Institutions

Publication Details

Journal
Cortex
Published
2025-05-06
DOI
https://doi.org/10.1016/j.cortex.2025.04.008
Citations
2
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
2.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic apathy following a major depressive episode: What is it?

Antoine Delcul, Laurent Cohen, Alexandre Morin, Amélie Ponchel et al.
2 citations
Cortex
Treatment of Major Depression
2.79
article

Chronic apathy following a major depressive episode: What is it?

Antoine Delcul, Laurent Cohen, Alexandre Morin, Amélie Ponchel, Thomas Mauras, David Bendetowicz, Philippe Fossati, Maeva Camus, Carole Azuar, Guilhem Carle, Richard Lévy, Julie Bernard, Ginevra Uggocioni
article en
2 citations

Abstract

Distinguishing between neurological and psychiatric disorders can be challenging, particularly when apathy serves as the primary symptom, as it is a common manifestation in both neurodegenerative diseases and mood disorders. We present a cohort of 11 patients (7 females and 4 males) aged over 50 years (mean age 61.36 ± 5.870 SD). These individuals exhibited a prolonged and isolated apathy lasting over a year, without concurrent dysthymia, but with a history of a preceding major depressive episode. This article aims to comprehensively profile these patients and to explore whether this condition represents an unconventional clinical presentation of a well-established disorder or introduces a hitherto unrecognized clinical entity. Key characteristics of this group included the following: sustained use of one or more typically effective antidepressant medications during the depressive episode prior to the onset of apathy, with no improvement of apathy during follow-up; a partial response to a single dose of zolpidem; the presence of a dysexecutive syndrome, with minimal or absent neurological signs except for mild extrapyramidal signs in a subset of patients; and the identification of mesial frontal abnormalities in neuroimaging studies (involving atrophy and/or hypoperfusion and/or hypometabolism) in eight patients. Only two patients received a neurological diagnosis during follow-up, characterized by a DAT Scan suggestive of Parkinson's disease. The underlying cause of this syndrome remains uncertain, possibly multifactorial, and yet to be determined. To advance understanding and treatment of this condition, it is imperative for neurologists and psychiatrists to be aware of and recognize this syndrome.

CortexVol. 188
Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Centre Hospitalier Universitaire de Toulouse (FR), Sorbonne Université (FR), Institut des Maladies Neurodégénératives (FR), Assistance Publique – Hôpitaux de Paris (FR), Pitié-Salpêtrière Hospital (FR), FHU Neurovasc (FR), Institut du Cerveau (FR), Centre Hospitalier Universitaire de Rouen (FR), Université de Rouen Normandie (FR)
Gender equality
Openalex Percentile: Top 11%
Treatment of Major Depression
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.